← back to search

Daniel P. Rakiec

Novartis (China) · CN
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Melanoma and MAPK Pathways, CRISPR and Genetic Engineering, Cutaneous Melanoma Detection and Management, and Protein Degradation and Inhibitors.
h-index
16
citations
3,121
works
137
NIH funding
primary concept
email

Recent publications

The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer
Cell Reports 2019cited by 92position: middledoi
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
Nature Medicine 2015cited by 525position: middledoi
An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
Cancer Discovery 2013cited by 561position: middledoi
CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development
Nature Genetics 2012cited by 105position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

William R. Sellers · Broad Institute2 papers (2013–2015)Joshua M. Korn · Novartis (Switzerland)2 papers (2013–2015)David A. Ruddy · University of Leicester2 papers (2013–2015)Vesselina G. Cooke · University of Delaware2 papers (2013–2015)Frank Stegmeier · Q Therapeutics (United States)2 papers (2013–2015)Thomas M. Roberts · University of London1 papers (2013–2013)Alina Raza · Novartis (Switzerland)1 papers (2015–2015)Jennifer N. Partlow · Boston Children's Hospital1 papers (2012–2012)Xueliang Gao · Medical University of South Carolina1 papers (2013–2013) · 1 papers (2015–2015)Manav Korpal · Novartis (Switzerland)1 papers (2013–2013) · 1 papers (2013–2013)Robert Hill · Broad Institute1 papers (2012–2012)Viveksagar Krishnamurthy Radhakrishna · Novartis (Switzerland)1 papers (2015–2015)Vijay Ganesh · Georgia Institute of Technology1 papers (2012–2012)Katie L. Kathrein · University of South Carolina1 papers (2012–2012)Wen‐Hann Tan · Princeton University1 papers (2012–2012)Nicholas Keen · Novartis (Switzerland)1 papers (2015–2015)William B. Dobyns · University of Minnesota1 papers (2012–2012)Derek Y. Chiang · University of Kentucky1 papers (2015–2015)